Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 07 2019
Historique:
received: 06 02 2019
accepted: 25 06 2019
entrez: 12 7 2019
pubmed: 12 7 2019
medline: 21 10 2020
Statut: epublish

Résumé

Although natural killer (NK) cells play a crucial role in the maintenance of a successful pregnancy, their cytotoxic activity should be tightly controlled. We hypothesized that endometrial mesenchymal stromal/stem cells (eMSCs) could potentially attenuate the functional features of NK cells. Herein, we assessed immunomodulatory effects of menstrual blood-derived stromal/stem cells (MenSCs), as a surrogate for eMSCs, on NK cells function. Our results showed that MenSCs induced proliferation of NK cells. However, IFN-γ/IL-1β pretreated MenSCs significantly inhibited NK cell proliferation. Of 41 growth factors tested, MenSCs produced lower levels of insulin-like growth factor binding proteins (IGFBPs) 1-4, VEGF-A, β-NGF, and M-CSF compared to bone marrow-derived mesenchymal stem cells (BMSCs). MenSCs displayed high activity of IDO upon IFN-γ treatment. The antiproliferative potential of IFN-γ/IL-1β-pretreated MenSCs was mediated through IL-6 and TGF-β. MenSCs impaired the cytotoxic activity of NK cells on K562 cells, consistent with the lower expression of perforin, granzymes A, and B. We also observed that in vitro decidualization of MenSCs in the presence of IFN-γ reduced the inhibitory effect of MenSCs on NK cell cytotoxicity against K562 target cells. Additionally, MenSCs were found to be prone to NK cell-mediated lysis in an MHC-independent manner. Our findings imply that dysregulation of NK cells in such pregnancy-related disorders as miscarriage may stem from dysfunctioning of eMSCs.

Identifiants

pubmed: 31292483
doi: 10.1038/s41598-019-46316-3
pii: 10.1038/s41598-019-46316-3
pmc: PMC6620360
doi:

Substances chimiques

IL6 protein, human 0
Interleukin-1beta 0
Interleukin-6 0
Transforming Growth Factor beta 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10007

Références

Blood. 2009 Jun 25;113(26):6576-83
pubmed: 19398717
Clin Exp Immunol. 2009 Apr;156(1):149-60
pubmed: 19210524
J Immunol. 2009 Apr 1;182(7):4085-92
pubmed: 19299706
Blood. 2008 Mar 15;111(6):3108-15
pubmed: 18187664
Blood. 2002 May 15;99(10):3838-43
pubmed: 11986244
Immunol Lett. 2014 Dec;162(2 Pt B):239-46
pubmed: 25455606
Blood. 2011 Sep 22;118(12):3254-62
pubmed: 21803852
Cell Prolif. 2014 Dec;47(6):615-23
pubmed: 25252214
J Obstet Gynaecol Res. 2012 May;38(5):804-9
pubmed: 22436017
Nat Med. 2006 Sep;12(9):1065-74
pubmed: 16892062
Stem Cells. 2008 Jan;26(1):279-89
pubmed: 17962701
Hum Reprod Update. 2012 Jul;18(4):458-71
pubmed: 22523109
Infect Immun. 1999 Nov;67(11):5615-20
pubmed: 10531207
Eur J Immunol. 2013 Jul;43(7):1862-72
pubmed: 23616249
PLoS One. 2014 Feb 05;9(2):e86075
pubmed: 24505254
Cell Biol Int. 2014 May;38(5):615-24
pubmed: 24446420
PLoS One. 2012;7(7):e41869
pubmed: 22848642
Transpl Immunol. 2016 Jul;37:1-9
pubmed: 27142560
Nat Rev Immunol. 2002 Sep;2(9):656-63
pubmed: 12209134
Biol Blood Marrow Transplant. 2008 Sep;14(9):1031-1038
pubmed: 18721766
Mol Biotechnol. 2014 Mar;56(3):223-31
pubmed: 24037410
Cell Commun Signal. 2014 Sep 30;12:63
pubmed: 25266361
J Reprod Immunol. 2014 Jun;103:9-17
pubmed: 24725996
Int J Hematol. 2012 May;95(5):484-93
pubmed: 22527849
Blood. 2003 Sep 1;102(5):1569-77
pubmed: 12730110
Stem Cell Res Ther. 2015 Mar 17;6:32
pubmed: 25889741
Placenta. 2008 Mar;29 Suppl A:S60-6
pubmed: 18039547
Reproduction. 2016 Nov;152(5):R159-66
pubmed: 27430234
Blood. 2008 Feb 1;111(3):1327-33
pubmed: 17951526
Stem Cells Dev. 2012 May 20;21(8):1333-43
pubmed: 21867426
Blood. 2006 Feb 15;107(4):1484-90
pubmed: 16239427
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2402-7
pubmed: 21248224
Hum Reprod. 2008 Oct;23(10):2282-91
pubmed: 18621754
Stem Cell Rev Rep. 2013 Apr;9(2):184-9
pubmed: 23397451
Stem Cell Res Ther. 2010 May 04;1(2):11
pubmed: 20637060
Stem Cells. 2006 Jan;24(1):74-85
pubmed: 16099998
Br J Haematol. 2005 Apr;129(1):118-29
pubmed: 15801964
J Immunol. 2010 Oct 1;185(7):3913-8
pubmed: 20802153
Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:284-8
pubmed: 25195203
Blood. 2005 Feb 15;105(4):1815-22
pubmed: 15494428
Reprod Biol Endocrinol. 2017 Aug 15;15(1):66
pubmed: 28810880
Proc Natl Acad Sci U S A. 2010 Jun 29;107(26):11918-23
pubmed: 20547831
Oncol Lett. 2018 Nov;16(5):6458-6464
pubmed: 30405783
Nat Commun. 2013;4:1479
pubmed: 23403580
J Reprod Immunol. 2010 Jan;84(1):1-7
pubmed: 20004979
Stem Cells. 2006 Feb;24(2):386-98
pubmed: 16123384
J Exp Med. 2003 Oct 20;198(8):1201-12
pubmed: 14568979
Int J Artif Organs. 2012 Jan;35(1):55-66
pubmed: 22307334
J Immunol. 2008 Aug 1;181(3):1869-76
pubmed: 18641324
PLoS One. 2014 Feb 20;9(2):e89006
pubmed: 24586479
Tissue Eng Part A. 2009 Oct;15(10):2795-806
pubmed: 19231921
Methods Mol Biol. 2013;1058:149-69
pubmed: 23592035
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2010 Sep;26(9):849-51
pubmed: 20815979
Tissue Eng Part A. 2012 Aug;18(15-16):1720-8
pubmed: 22571521
Endocr Rev. 2005 Feb;26(1):44-62
pubmed: 15689572
Asian Pac J Trop Med. 2015 Sep;8(9):739-46
pubmed: 26433660
Cell. 2004 May 14;117(4):515-26
pubmed: 15137944

Auteurs

Mohammad-Reza Shokri (MR)

Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Mahmood Bozorgmehr (M)

Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Alireza Ghanavatinejad (A)

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Reza Falak (R)

Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. falak.r@iums.ac.ir.

Mehdi Aleahmad (M)

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Somaieh Kazemnejad (S)

Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.

Fazel Shokri (F)

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Amir-Hassan Zarnani (AH)

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. zarnania@tums.ac.ir.
Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. zarnania@tums.ac.ir.
Immunology Research Center, Iran University of Medical Sciences, Tehran, Iran. zarnania@tums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH